Literature DB >> 21070773

Per3, a circadian gene, is required for Chk2 activation in human cells.

Jun-Sub Im1, Bo-Hyeon Jung, Sang-Eun Kim, Kun-Ho Lee, Joon-Kyu Lee.   

Abstract

PER3 is a member of the PERIOD genes, but does not play essential roles in the circadian clock. Depletion of Per3 by siRNA almost completely abolished activation of checkpoint kinase 2 (Chk2) after inducing DNA damage in human cells. In addition, Per3 physically interacted with ATM and Chk2. Per3 overexpression induced Chk2 activation in the absence of exogenous DNA damage, and this activation depended on ATM. Per3 overexpression also led to the inhibition of cell proliferation and apoptotic cell death. These combined results suggest that Per3 is a checkpoint protein that plays important roles in checkpoint activation, cell proliferation and apoptosis.
Copyright © 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21070773     DOI: 10.1016/j.febslet.2010.11.003

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Functional polymorphisms of circadian negative feedback regulation genes are associated with clinical outcome in hepatocellular carcinoma patients receiving radical resection.

Authors:  Zhaohui Zhang; Fei Ma; Feng Zhou; Yibing Chen; Xiaoyan Wang; Hongxin Zhang; Yong Zhu; Jianwei Bi; Yiguan Zhang
Journal:  Med Oncol       Date:  2014-10-26       Impact factor: 3.064

2.  Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancy.

Authors:  Wendy W Hwang-Verslues; Po-Hao Chang; Yung-Ming Jeng; Wen-Hung Kuo; Pei-Hsun Chiang; Yi-Cheng Chang; Tsung-Han Hsieh; Fang-Yi Su; Liu-Chen Lin; Serena Abbondante; Cheng-Yuan Yang; Huan-Ming Hsu; Jyh-Cherng Yu; King-Jen Chang; Jin-Yuh Shew; Eva Y-H P Lee; Wen-Hwa Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-08       Impact factor: 11.205

3.  Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma.

Authors:  Emily A Slat; Jasmin Sponagel; Luciano Marpegan; Tatiana Simon; Najla Kfoury; Albert Kim; Andrea Binz; Erik D Herzog; Joshua B Rubin
Journal:  J Biol Rhythms       Date:  2017-03-16       Impact factor: 3.182

Review 4.  Running for time: circadian rhythms and melanoma.

Authors:  Elitza P Markova-Car; Davor Jurišić; Nataša Ilić; Sandra Kraljević Pavelić
Journal:  Tumour Biol       Date:  2014-04-14

5.  MGMT expression and pituitary tumours: relationship to tumour biology.

Authors:  Ann McCormack; Warren Kaplan; Anthony J Gill; Nicholas Little; Raymond Cook; Bruce Robinson; Roderick Clifton-Bligh
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

6.  Nucleotide excision repair efficiency in quiescent human fibroblasts is modulated by circadian clock.

Authors:  Leonardo Bee; Selena Marini; Giovanna Pontarin; Paola Ferraro; Rodolfo Costa; Urs Albrecht; Lucia Celotti
Journal:  Nucleic Acids Res       Date:  2015-02-06       Impact factor: 16.971

7.  Transcriptomic characterization of cold acclimation in larval zebrafish.

Authors:  Yong Long; Guili Song; Junjun Yan; Xiaozhen He; Qing Li; Zongbin Cui
Journal:  BMC Genomics       Date:  2013-09-11       Impact factor: 3.969

8.  Hepatitis B virus X protein disrupts the balance of the expression of circadian rhythm genes in hepatocellular carcinoma.

Authors:  Sheng-Li Yang; Chao Yu; Jian-Xin Jiang; Li-Ping Liu; Xiefan Fang; Chao Wu
Journal:  Oncol Lett       Date:  2014-09-26       Impact factor: 2.967

Review 9.  CHK2 kinase in the DNA damage response and beyond.

Authors:  Laura Zannini; Domenico Delia; Giacomo Buscemi
Journal:  J Mol Cell Biol       Date:  2014-11-17       Impact factor: 6.216

10.  Expression of PER, CRY, and TIM genes for the pathological features of colorectal cancer patients.

Authors:  Yong Wang; Yunsheng Cheng; Gang Yu; Benli Jia; Zhihang Hu; Lijiu Zhang
Journal:  Onco Targets Ther       Date:  2016-04-05       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.